Medtronic Plc (MDT) observed significant
trading activity from several institutional investors. Many investment firms and funds have
increased their holdings in MDT, including
Boone Capital Management LLC and
Adage Capital Partners GP L.L.C., contributing to MDT's robust market presence. Conversely, some parties, such as
Bellevue Group AG and
Benjamin Edwards Inc., reduced their shares in MDT, reflecting a variance in market sentiment. Amidst differing stake alterations, institutional investors like
Marshall Wace LLP have increased their positions. In recent reports, MDT presented strong Q2 fiscal 2026 results, which has accounted for
amplified momentum. Barclays adjusted MDT's forecast following the encouraging earnings report, triggering raised price targets. Furthermore, Medtronic CEO was revered as one of the "finest people" by Jim Cramer. Additionally, Medtronic also announced a dividend for Q3 of fiscal 2026 and successfully launched its MiniMed 780G system in the U.S. Tailored to concerns about the company's valuation, recent strong earnings, an upgraded outlook, and new product wins offer strong counterpoints.
Medtronic Plc MDT News Analytics from Thu, 24 Jul 2025 07:00:00 GMT to Sat, 13 Dec 2025 13:43:23 GMT -
Rating 7
- Innovation 8
- Information 9
- Rumor -4
